<html>
<head>PUBMED IDs for LMTK2</head>
<body bgcolor='#C5F0F2'><h1>LMTK2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18264097/'>Multiple newly identified loci associated with prostate cancer susceptibility.</a> February 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18429820/'>BREK/LMTK2 is a myosin VI-binding protein involved in endosomal membrane trafficking.</a> April 24  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19050691/'>Identification of new genetic risk factors for prostate cancer.</a> December 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19449426/'>Characterization of the complex 7q21.3 rearrangement in a patient with bilateral split-foot malformation and hearing loss.</a> July 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19449424/'>Mosaicism in Marshall syndrome.</a> July 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19806447/'>LMTK2 and PARP-2 gene polymorphism and azoospermia secondary to meiotic arrest.</a> April 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19855435/'>Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis.</a> February 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20569440/'>Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.</a> February 4  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21996745/'>Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo.</a> August 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22975805/'>The transcriptional landscape and mutational profile of lung adenocarcinoma.</a> April 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23985253/'>[Association of TET2, LMTK2 and FAM84B gene expression with prostate cancer risk in Chinese patients].</a> January 28  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26008968/'>Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy.</a> May 14  2015<br></body></html>
